Trends in overall survival and costs of multiple myeloma, 2000–2014 | Leukemia
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry | Haematologica
Overall survival of 3664 patients with multiple myeloma, according to... | Download Scientific Diagram
Duration of Survival in Patients with Myeloma Treated with Thalidomide | NEJM
Age-dependent overall survival of 2,907 newly diagnosed Danish patients... | Download Scientific Diagram
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome | Blood Cancer Journal
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press
Overall survival (OS) in 253 patients with multiple myeloma... | Download Scientific Diagram
Frontiers | Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry | Haematologica
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial - The Lancet
Trends in the multiple myeloma treatment landscape and survival: a U.S. analysis using 2011–2019 oncology clinic electronic he
Myeloma survival statistics | Cancer Research UK
Disparities in Care and Outcomes
Impact of Novel Therapies on Multiple Myeloma Survival– Current and Future Outcomes - Clinical Lymphoma, Myeloma and Leukemia
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press
del(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma - ScienceDirect
Mayo Clinic Rochester Publishes Updated Multiple Myeloma Survival Rates! - Multiple Myeloma - Survival Rate Statistics by Hospital
Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project | Blood Cancer Journal
Kaplan-Meier curves for overall survival for patients with genetic... | Download Scientific Diagram
A Multiple Myeloma Roundtable: Treatment Trends and Recent Clinical Advances
Daratumumab, Lenalinomide, and Dexamethasone for Myeloma | NEJM Resident 360
Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experience | Cancer Communications | Full Text
